8-KCorporate ChangesExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Bylaw Amendment (Nov 5, 2008)

Filed November 5, 2008For Securities:DGX

Summary

This Form 8-K filing by Quest Diagnostics Incorporated (DGX) on November 5, 2008, reports amendments made to its Amended and Restated By-Laws effective October 31, 2008. The primary focus of these amendments is to refine and clarify the procedures for stockholder nominations of directors and the submission of other business proposals for consideration at company meetings. These changes aim to provide greater clarity on when and how stockholders can propose nominations or new business, including specific notice periods, required disclosures about the stockholder's intentions, and conditions for participation. The amendments also address the process for board size increases and nominations at special meetings. While not a financial update, these by-law changes are significant for corporate governance and investor engagement, impacting how shareholders can participate in company decision-making and board composition.

Key Highlights

  • 1Amendments to Quest Diagnostics' Amended and Restated By-Laws were made effective October 31, 2008.
  • 2The primary purpose of the amendments is to clarify procedures for stockholder nominations of directors and the submission of other business proposals.
  • 3Key changes include defining a "window period" for stockholder notice of proposed business and director nominations.
  • 4New requirements are in place for stockholders submitting proposals, such as providing the text of proposed business and disclosing relevant agreements or hedging activities.
  • 5The amendments clarify the process for announcing board size increases and nominations at special stockholder meetings.
  • 6Stricter requirements are introduced for stockholders or their representatives to appear at meetings to present proposed business.
  • 7The filing confirms that compliance with these by-law sections is the exclusive means for stockholders to make nominations or submit business, except for proposals under SEC Rule 14a-8.

Frequently Asked Questions

The main purpose is to provide clearer and more structured procedures for stockholders who wish to nominate directors or propose other business for consideration at company meetings. This includes defining specific timelines and disclosure requirements for such actions.

The amendments clarify that nominations must be made within a specific 'window period' and require the nominating stockholder to meet certain eligibility and disclosure criteria, including ensuring they are entitled to vote and intend to appear at the meeting. Compliance with these by-laws is the exclusive method, barring certain exceptions.

Yes, stockholders submitting business proposals (other than director nominations) must now provide the text of the proposed business, describe related agreements or hedging activities that might affect their voting power or stock disposition, and represent their entitlement to vote and intention to attend the meeting.

The amendments clarify the process for announcing potential increases in the size of the Board of Directors and align these announcements with the established 'window period' for nominations. They also clarify the election of directors at special meetings.